Incorporation of 35SO42-into adenosine 5'-phosphosulfate (APS), 3'-phosphoadenosine 5'-phosphosulfate (PAPS), and chondroitin sulfate was simultaneously assessed with extracts prepared from epiphyseal cartilage of neonatal normal or homozygous brachymorphic mice. Radioactivity measured in APS, PAPS, and chondroitin sulfate of extracts from brachymorphic cartilage was approximately 300%, 9%, and 13% of the normal levels, respectively. Even (2) . The mutant cartilage contains normal levels and types of collagen as well as normal levels of glycosaminoglycans (3). However, both the sulfate content in the cartilage and the incorporation of labeled sulfate is lower in mutant cartilage than in normal cartilage (3). The glycosaminoglycans from the mutant cartilage are found to be less negatively charged than those from normal cartilage on the basis of ion-exchange chromatography and electrophoresis (3). After digestion with chondroitinase, larger amounts of nonsulfated glycosaminoglycan disaccharide were obtained from the mutant cartilage (3 A breeding colony was established from homozygous brachymorphic (bm/bm) mice obtained from the Jackson Laboratory (Bar Harbor, ME). Cartilage tissue was obtained from 4-day-old homozygous brachymorphic and normal C57BL/6J mice by dissection of distal femoral heads and proximal tibial heads as described (5). Cartilage tissue was homogenized at 4VC in 0.05 M Tris-HCI, pH 8.0, or 0.1 M Tris-HCI, pH 8.5, depending on the experiments. Enzyme assays were performed on 10,000 X g supernatant fluids of the homogenates. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Brachymorphism in mice is characterized by disproportionately short stature (1) . The cartilage matrix of homozygous recessive brachymorphic mice (bm/bm) reacts poorly with stains for sulfated glycosaminoglycans (2) . The mutant cartilage matrix contains normal collagen fibrils, but the proteoglycan aggregate granules are smaller than normal and are present in reduced numbers, particularly in the columnar hypertrophic zones of the growth plate (2) . The mutant cartilage contains normal levels and types of collagen as well as normal levels of glycosaminoglycans (3) . However, both the sulfate content in the cartilage and the incorporation of labeled sulfate is lower in mutant cartilage than in normal cartilage (3) . The glycosaminoglycans from the mutant cartilage are found to be less negatively charged than those from normal cartilage on the basis of ion-exchange chromatography and electrophoresis (3) . After digestion with chondroitinase, larger amounts of nonsulfated glycosaminoglycan disaccharide were obtained from the mutant cartilage (3 (4) . In contrast, when sulfation was initiated from ATP and 5S042-, a reduction to less than 25% in sulfate incorporation into chondroitin sulfate proteoglycan was observed (4 After 60 min of incubation, the reaction was terminated by boiling for 3 min. PAPS formation was determined by the method of Gregory and Lipmann (8) . This assay is based on the measurement of liberation of p-nitrophenol from its sulfate as determined by a change in absorbance at 400 nm, usually within a small range (0.015-0.065). However, the method is so sensitive and specific for PAPS that the significant differences in APS kinase activity can be determined. ATP Sulfurylase Assay. ATP sulfurylase (sulfate adenylyltransferase; ATP:sulfate adenylyltransferase, EC 2.7.7.4) was assayed according to Robbins (9) by the measurement of the rate of inorganic phosphate release from ATP in the presence of molybdate and pyrophosphatase. The reaction is based on the fact that molybdate may substitute for sulfate as substrate for ATP-sulfurylase (10) . The advantage of this method is that the reaction product, adenosine phosphomolybdate, is unstable and hydrolyzes spontaneously, and therefore, results in no product inhibition. In contrast, the physiological reaction product, APS, strongly inhibits ATP sulfurylase ( RESULTS A possible defect in the sulfation pathway during synthesis of PAPS from ATP and MSO42-in bin/bin cartilage was suggested from the results obtained in the previous study (4) . Consequently, the individual steps involved in this pathway that could alter APS or PAPS synthesis were assessed.
[355]APS, [35SIPAPS, and MsS-labeled endogenous products were simultaneously determined by paper electrophoresis after incubation of cartilage extracts from normal or brachymorphic mice with H2asSO4. After 50 min of incubation, normal cartilage extracts utilized approximately 14.3% of the radioactive sulfate, while brachymorphic cartilage extracts utilized only 2.4%. As shown in Fig. 1 , incorporation of 5S0442-into endogenous acceptors with brachymorphic cartilage extracts attained only 12.6% of the normal level and is consistent with the observations previously reported (4) . The accumulated [asSIPAPS in extracts of mutant cartilage was only 8.7% of that in normal extracts, confirming that PAPS synthesis is defective as suggested from the previous study (4) . Thus, the decreased incorporation of 35S042-into endogenous acceptors is presumably due to the limited supply of [asS]PAPS as discussed below.
In contrast, accumulated [35SIAPS was approximately 300% of the normal level. However, because radioactivity incorporated into both PAPS and macromolecular products is derived from that first incorporated into APS, the radioactive sulfate utilized reflects the total APS produced during the incubation. Thus, APS produced in the mutant cartilage extracts was only 17% of that in the normal. However, it is unlikely, as discussed below, that the defect results from decreased APS synthesis rather than the conversion of APS to PAPS.
On the basis of the results shown in Fig. 1 , percentage of conversion of APS to PAPS at each assay time was calculated. If one defines the amount of each product in terms of cpm, then the percent conversion may be determined as follows: % conversion of APS to PAPS 100 X (CPm PAPS + cpm macromolecular product)/(cpm APS + cpm PAPS + cpm macromolecular product). Corrections were not made for the possible degradation of each component. In the case of normal cartilage extracts, the percentage of conversion was found to be 9%c95% throughout the reaction period (Fig. 2) . In contrast, the mutant cartilage extracts yielded 18, 25, 40, and 55% after incubation of 6, 10, 27 and 50 min, respectively. Thus, the percentage of conversion of APS to PAPS was significantly decreased in the mutant cartilage extracts even though total APS produced was less than 20% of that in the normal extracts. This finding appears to support the defective conversion of APS to PAPS.
In order to clarify which step of PAPS synthesis is defective, the specific enzymes involved were assayed directly. Colorimetric enzyme assays were used for the ATP sulfurylase and APS kinase. APS kinase was assayed in extracts obtained from Table 2 , a decrease to approximately 1/2 in ATP sulfurylase in brachymorphic cartilage extracts was observed with a preparation from frozen as well as from freshly sacrificed mice. This reduction in ATP sulfurylase activity may be a secondary phenomenon, as discussed below. These results demonstrate that the primary defect results from a defect in the enzymic step of PAPS synthesis rather than APS synthesis. However, there still remains a possibility that the defect results from an increased degradation rather than a decreased synthesis of PAPS, because the APS kinase activity was measured by quantitation of newly synthesized PAPS.
DISCUSSION
These results confirm and extend the previous finding of a substantial reduction in sulfation of glycosaminoglycans by extracts of cartilage from brachymorphic mice (3, 4) . The defect in the sulfation pathway in the synthesis of PAPS in bm/bm cartilage, which was suggested from the previous study (4) , has now been localized to a single enzymic step by two different approaches. When the amounts of the three reaction products (APS, PAPS, and chondroitin sulfate) were measured, formation of PAPS and subsequent sulfation of chondroitin sulfate were reduced to less than 15% in mutant cartilage extracts. The conversion of APS to PAPS was nearly quantitative in extracts of normal cartilage, but far less efficient in extracts of brachymorphic mice, suggesting a primary block in the pathway of conversion of APS to PAPS. Presumably because of this reduction in conversion, more APS accumulates in the mutant cartilage extracts. Although more [35S]APS was accumulated in the mutant, this amount was not comparable to the decrease in PAPS synthesized as might be expected if a defect occurred in conversion of APS to PAPS. This is presumably due to a feedback inhibition by APS on its synthesis, because APS is known to strongly inhibit this synthesis (7) . In fact, the APS level increased somewhat even though it was utilized far less efficiently in the mutant. In additional experiments, no increased hydrolysis of APS was observed by the mutant when [-5S]APS was incubated with cartilage extracts (unpublished observations), suggesting that the reduction in total synthesis of APS does not result from possible degradation.
Percent consumption of newly synthesized PAPS was calculated by the following equation: % consumption of PAPS = 100 X (cpm macromolecular product)/(cpm PAPS + cpm macromolecular product). Less than 6% of newly synthesized PAPS was utilized for sulfation of endogenous acceptor in both Medical Sciences: Sugahara and Schwartz 6618 Medical Sciences: Sugahara and Schwartz normal and mutant cartilage extracts. In spite of such an apparent excess of PAPS, markedly less radioactivity was incorporated into endogenous acceptors by mutant cartilage extracts (Fig. 1) . Presumably, this is not due to lower sulfotransferase activities but rather is due to a decreased PAPS concentration. In the previous study in which comparable levels of sulfotransferase activities were observed in extracts of normal and mutant cartilage (4), the PAPS concentration utilized (9 ,M) was more than 1000 times greater than that of PAPS produced by the cartilage extracts in the present study. Concentrations of newly synthesized [a5S]PAPS in the experiments shown in Fig. 1 were calculated to be approximately 9 or 0.9 nM in extracts of normal or mutant cartilage, respectively. Therefore, it may be inferred that this 10-fold difference in PAPS concentration at this low level resulted in the difference in sulfation of endogenous chondroitin sulfate, although comparable levels of sulfotransferase activities could be detected in the presence of an excess of PAPS (4) .
The defective APS kinase activity was confirmed by measurement of the activities of ATP sulfurylase and APS kinase. The latter enzyme activity was decreased to less than 1/13 in bm/bin cartilage, concomitant with the observed reduction of PAPS formation shown in Fig. 1 . ATP sulfurylase levels were also consistently found to be lower in mutant tissue than in normals. The reduction in ATP sulfurylase may be a secondary phenomenon due to the inhibition by APS, which presumably accumulates in the mutant tissue. Alternatively, the marked inhibition produced in the PAPS synthetic pathway by the substantial reduction in APS kinase levels may cause a secondary decrease in ATP sulfurylase levels.
The possibility exists that the defect is due to reduced APS kinase activity or the production of an inhibitor. The latter seems unlikely, because in preliminary mixing experiments intermediate activity levels were observed (unpublished observations). It remains to be determined whether there is a reduction in enzyme protein or an abnormal enzyme molecule. Furthermore, it is possible that the apparent decreased APS kinase activity is due to increased degradation of newly synthesized PAPS. However, it is firmly established that the defect in brachymorphic cartilage is due to decreased levels of PAPS synthesis rather than APS synthesis.
PAPS is thought to be an intermediate for synthesis of all naturally occurring sulfated compounds, including sulfated glycoproteins (12) , fibronectins (13) , sulfatides (14) , and glycosaminoglycans. It is, therefore, somewhat surprising that the defect in PAPS synthesis does not result in more severe lesions. However, APS kinase activity was found to be profoundly, but not completely, deficient in brachymorphic mice. Perhaps the PAPS concentration may not be adequate for synthesis of large amounts of highly sulfated proteoglycans as found in cartilage and hence, the primary lesion is expressed as a growth disorder in cartilagenous tissue. In additional experiments, decreased PAPS formation has also been demonstrated in liver extracts of brachymorphic mice, indicating a more widespread distribution of the defective pathway (unpublished observations). However, decreased PAPS formation was not observed in skin extracts, consistent with the previous report of no differences in the electrophoretic properties of glycosaminoglycans from brachymorphic and normal mouse skin (3). These results suggest that there may be two genetically distinct APS kinases.
A defect in biosynthesis of sulfated proteoglycans has thus been found. A disorder in ganglioside biosynthesis in man has been shown to result from a deficient UDP-GalNAc:GM3 Nacetylgalactosaminyltransferase (15) and represents the only other report of a defect in biosynthesis of a complex carbohydrate-containing macromolecule. The present studies open up a new range of possibilities for study of growth disorders, especially because this defect is primarily expressed in cartilage.
